Over the past 12 months, 2 insiders at Kailera Therapeutics, Inc. filed 2 open-market SEC Form 4 transactions on KLRA: 2 purchases worth $159.4M and 0 sales worth $0. Insiders have been net buyers over this period. The most recent filing was on Apr 20, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 20, 26 | Bain Capital Investors Llc | BUY | 8.40M | $16.00 | $134.4M |
| Apr 20, 26 | Bain Capital Life Sciences Investors, Llc | BUY | 1.56M | $16.00 | $25.0M |
Over the past 12 months, insiders at Kailera Therapeutics, Inc. filed 2 open-market purchases worth $159.4M and 0 sales worth $0 on KLRA, which makes them net buyers over the period. The most recent Form 4 was filed on Apr 20, 26.
The largest recent open-market KLRA insider purchase in our data was $134.4M by Bain Capital Investors Llc, filed on Apr 20, 26.
2 different insiders at Kailera Therapeutics, Inc. filed open-market SEC Form 4 transactions on KLRA over the last 12 months.
InsiderTape plots every KLRA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Kailera Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →